|
COPS3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.099400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.790600E-01 |
| Normal-vs-Stage2 |
4.671600E-01 |
| Normal-vs-Stage3 |
2.676000E-01 |
| Normal-vs-Stage4 |
8.915600E-01 |
| Stage1-vs-Stage2 |
4.973600E-01 |
| Stage1-vs-Stage3 |
2.797800E-01 |
| Stage1-vs-Stage4 |
9.395400E-01 |
| Stage2-vs-Stage3 |
1.761800E-01 |
| Stage2-vs-Stage4 |
5.704400E-01 |
| Stage3-vs-Stage4 |
5.909200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.138400E-01 |
| Normal-vs-AfricanAmerican |
5.013200E-01 |
| Normal-vs-Asian |
4.906400E-01 |
| Caucasian-vs-AfricanAmerican |
5.675600E-01 |
| Caucasian-vs-Asian |
3.199600E-01 |
| AfricanAmerican-vs-Asian |
3.969600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.163400E-01 |
| Normal-vs-Female |
2.406400E-01 |
| Male-vs-Female |
1.649030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.335800E-01 |
| Normal-vs-Extreme_Weight |
9.751800E-01 |
| Normal-vs-Obese |
4.827400E-01 |
| Normal-vs-Extreme_Obese |
4.858200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.241400E-01 |
| Normal_Weight-vs-Obese |
4.060200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.880200E-01 |
| Extreme_Weight-vs-Obese |
5.439000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.037400E-01 |
| Obese-vs-Extreme_Obese |
2.574600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.890000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.094800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.301400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.021560E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.362800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.094350E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.687650E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.047900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.465530E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.107590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.142600E-01 |
| Normal-VS-Type2 PRCC |
2.657200E-01 |
| Normal-VS-KIRP CIMP |
1.695560E-01 |
| Normal-VS-Unclassified PRCC |
9.786400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.344500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.563000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.650000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.494100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.232800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.722040E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.358400E-01 |
| Normal-vs-N1 |
5.299800E-02 |
| Normal-vs-N2 |
4.255800E-03 |
| N0-vs-N1 |
1.069510E-02 |
| N0-vs-N2 |
2.906600E-01 |
| N1-vs-N2 |
3.718000E-02 |
|
|
